Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Spaander, Manon C. W."" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-9 z 9
    Tytuł:
    A digital intake tool to avert outpatient visits in a FIT-based colorectal cancer screening population: study protocol of a multicentre, prospective non-randomized trial - the DIT-trial.
    Autorzy:
    Marijnissen FE; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
    de Jonge PJF; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
    Erler NS; Department of Biostatistics, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.; Department of Epidemiology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
    Ismail SY; Department of Psychiatry, Section Medical Psychology and Psychotherapy, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
    Lansdorp-Vogelaar I; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, the Netherlands.
    Spaander MCW; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, the Netherlands. v.spaander@erasmusmc.nl.
    Pokaż więcej
    Źródło:
    BMC gastroenterology [BMC Gastroenterol] 2024 Jan 18; Vol. 24 (1), pp. 38. Date of Electronic Publication: 2024 Jan 18.
    Typ publikacji:
    Clinical Trial Protocol; Journal Article
    MeSH Terms:
    Colorectal Neoplasms*/diagnosis
    Mass Screening*/methods
    Humans ; Colonoscopy/methods ; Early Detection of Cancer/methods ; Multicenter Studies as Topic ; Occult Blood ; Outpatients ; Prospective Studies ; Clinical Trials as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Personalized colorectal cancer screening: study protocol of a mixed-methods study on the effectiveness of tailored intervals based on prior f-Hb concentration in a fit-based colorectal cancer screening program (PERFECT-FIT).
    Autorzy:
    Breekveldt ECH; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Dr. Molewaterplein 40, 3015GD, Rotterdam, The Netherlands. .; Department of Gastroenterology and Hepatology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands. .
    Toes-Zoutendijk E; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Dr. Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
    de Jonge L; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Dr. Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
    Spaander MCW; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
    Dekker E; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centre - Location AMC, Amsterdam, The Netherlands.
    van Kemenade FJ; Department of Pathology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
    van Vuuren AJ; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
    Ramakers CRB; Department of Clinical Chemistry, Erasmus MC, University Medical Centre Rotterdam, Rotterdam, The Netherlands.
    Nagtegaal ID; Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.
    van Leerdam ME; Department of Gastroenterology and Hepatology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
    Lansdorp-Vogelaar I; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, Dr. Molewaterplein 40, 3015GD, Rotterdam, The Netherlands.
    Pokaż więcej
    Źródło:
    BMC gastroenterology [BMC Gastroenterol] 2023 Feb 22; Vol. 23 (1), pp. 45. Date of Electronic Publication: 2023 Feb 22.
    Typ publikacji:
    Clinical Trial Protocol; Journal Article
    MeSH Terms:
    Early Detection of Cancer*/methods
    Colorectal Neoplasms*/diagnosis
    Humans ; Occult Blood ; Hemoglobins/analysis ; Feces/chemistry ; Colonoscopy ; Mass Screening/methods ; Randomized Controlled Trials as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Modelling optimal use of temporarily restricted colonoscopy capacity in a FIT-based CRC screening program: Application during the COVID-19 pandemic.
    Autorzy:
    de Jonge L; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    van de Schootbrugge-Vandermeer HJ; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    Breekveldt ECH; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.; Department of Gastroenterology and Hepatology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
    Spaander MCW; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    van Vuuren HJ; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    van Kemenade FJ; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    Dekker E; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Location AMC, Amsterdam, The Netherlands.
    Nagtegaal ID; Department of Pathology, Radboud University Medical Centre, Nijmegen, The Netherlands.
    van Leerdam ME; Department of Gastroenterology and Hepatology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
    Lansdorp-Vogelaar I; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2022 Jun 24; Vol. 17 (6), pp. e0270223. Date of Electronic Publication: 2022 Jun 24 (Print Publication: 2022).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    COVID-19*/diagnosis
    COVID-19*/epidemiology
    Colorectal Neoplasms*/diagnosis
    Colorectal Neoplasms*/epidemiology
    Aged ; Child, Preschool ; Colonoscopy ; Early Detection of Cancer/methods ; Humans ; Mass Screening/methods ; Middle Aged ; Occult Blood ; Pandemics
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Socioeconomic differences in participation and diagnostic yield within the Dutch national colorectal cancer screening programme with faecal immunochemical testing.
    Autorzy:
    van der Meulen MP; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    Toes-Zoutendijk E; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    Spaander MCW; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    Dekker E; Department of Gastroenterology and Hepatology, Academic Medical Center, Academic University Medical Centers, Amsterdam, The Netherlands.
    Bonfrer JMG; Department of Clinical Chemistry, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
    van Vuuren AJ; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    Kuipers EJ; Department of Gastroenterology and Hepatology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    van Kemenade FJ; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    van Velthuysen MF; Department of Pathology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    Thomeer MGJ; Department of Radiology, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    van Veldhuizen H; Department of Quality Improvement, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    de Koning HJ; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    Lansdorp-Vogelaar I; Department of Public Health, Erasmus MC University Medical Center, Rotterdam, The Netherlands.
    van Leerdam ME; Department of Gastroenterology and Hepatology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
    Pokaż więcej
    Źródło:
    PloS one [PLoS One] 2022 Feb 17; Vol. 17 (2), pp. e0264067. Date of Electronic Publication: 2022 Feb 17 (Print Publication: 2022).
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Socioeconomic Factors*
    Colorectal Neoplasms/*diagnosis
    Early Detection of Cancer/*methods
    Ethnicity/*statistics & numerical data
    Feces/*chemistry
    Immunochemistry/*methods
    Aged ; Colonoscopy ; Colorectal Neoplasms/epidemiology ; Female ; Humans ; Male ; Middle Aged ; Netherlands/epidemiology ; Predictive Value of Tests
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Clinicopathological features and risk factors for developing colorectal neoplasia in Hodgkin's lymphoma survivors.
    Autorzy:
    Ykema BLM; Department of, 1Gastroenterology and Hepatology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Rigter LS; Department of, 1Gastroenterology and Hepatology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Spaander MCW; Department of Gastroenterology and Hepatology, Erasmus Medical Center University Hospital, Rotterdam, The Netherlands.
    Moons LMG; Department of, Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands.
    Bisseling TM; Department of, Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.
    Aleman BMP; Department of, Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Dekker E; Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam, The Netherlands.
    Verbeek WHM; Department of, 1Gastroenterology and Hepatology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Kuipers EJ; Department of Gastroenterology and Hepatology, Erasmus Medical Center University Hospital, Rotterdam, The Netherlands.
    de Boer JP; Department of, Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Lugtenburg PJ; Department of, 8Hematology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
    Janus CPM; Department of, Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
    Petersen EJ; Department of, Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
    Roesink JM; Department of, Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
    van der Maazen RWM; Department of, Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
    Meijer GA; Department of, Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Schaapveld M; Department of, Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    van Leeuwen FE; Department of, Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Carvalho B; Department of, Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Snaebjornsson P; Department of, Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    van Leerdam ME; Department of, 1Gastroenterology and Hepatology, Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
    Pokaż więcej
    Źródło:
    Digestive endoscopy : official journal of the Japan Gastroenterological Endoscopy Society [Dig Endosc] 2022 Jan; Vol. 34 (1), pp. 163-170. Date of Electronic Publication: 2021 Jun 08.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Colorectal Neoplasms*/epidemiology
    Colorectal Neoplasms*/etiology
    Hodgkin Disease*/epidemiology
    Hodgkin Disease*/etiology
    Adult ; Colonoscopy ; Humans ; Middle Aged ; Risk Factors ; Survivors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Clinicopathological characteristics of early onset colorectal cancer.
    Autorzy:
    Vuik FER; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Nieuwenburg SAV; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Nagtegaal ID; Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands.
    Kuipers EJ; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Spaander MCW; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Pokaż więcej
    Źródło:
    Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2021 Dec; Vol. 54 (11-12), pp. 1463-1471. Date of Electronic Publication: 2021 Oct 12.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Carcinoma, Signet Ring Cell*/epidemiology
    Colorectal Neoplasms*/diagnosis
    Colorectal Neoplasms*/epidemiology
    Colorectal Neoplasms*/pathology
    Rectal Neoplasms*/diagnosis
    Rectal Neoplasms*/epidemiology
    Rectal Neoplasms*/pathology
    Adolescent ; Adult ; Child, Preschool ; Female ; Humans ; Incidence ; Middle Aged ; Neoplasm Staging ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Diagnostic yield of colonoscopy surveillance in testicular cancer survivors treated with platinum-based chemotherapy: study protocol of a prospective cross-sectional cohort study.
    Autorzy:
    Ykema BLM; Department of Gastroenterology and Hepatology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands. .
    Bisseling TM; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.
    Spaander MCW; Department of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Moons LMG; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands.
    van der Biessen-van Beek D; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.
    Saveur L; Department of Gastroenterology and Hepatology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
    Kerst M; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Mulder SF; Department of Medical Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
    de Wit R; Department of Medical Oncology, Erasmus University Medical Center, Rotterdam, The Netherlands.
    Zweers D; Department of Medical Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
    Meijer GA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Beijnen JH; Department of Pharmacy and Pharmacology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Lansdorp-Vogelaar I; Department of Public Health, Erasmus University Medical Center, Rotterdam, The Netherlands.
    van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Snaebjornsson P; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    van Leerdam ME; Department of Gastroenterology and Hepatology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, The Netherlands.
    Pokaż więcej
    Źródło:
    BMC gastroenterology [BMC Gastroenterol] 2021 Feb 12; Vol. 21 (1), pp. 67. Date of Electronic Publication: 2021 Feb 12.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Cancer Survivors*
    Colorectal Neoplasms*/diagnosis
    Colorectal Neoplasms*/drug therapy
    Colorectal Neoplasms*/epidemiology
    Testicular Neoplasms*/drug therapy
    Cohort Studies ; Colonoscopy ; Cross-Sectional Studies ; Early Detection of Cancer ; Humans ; Male ; Middle Aged ; Multicenter Studies as Topic ; Platinum ; Prospective Studies ; Survivors
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Colorectal cancer surveillance in Hodgkin lymphoma survivors at increased risk of therapy-related colorectal cancer: study design.
    Autorzy:
    Rigter LS; Department of Gastroenterology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
    Spaander MC; Department of Gastroenterology and Hepatology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
    Moons LM; Department of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, The Netherlands.
    Bisseling TM; Department of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, The Netherlands.
    Aleman BM; Department of Radiation Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    de Boer JP; Department of Hematology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Lugtenburg PJ; Department of Hematology, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
    Janus CP; Department of Radiation Oncology, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
    Petersen EJ; Department of Hematology, University Medical Center Utrecht, Utrecht, The Netherlands.
    Roesink JM; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.
    Raemaekers JM; Department of Hematology, Radboud University Medical Center, Nijmegen, The Netherlands.
    van der Maazen RW; Department of Radiation Oncology, Radboud University Medical Center, Nijmegen, The Netherlands.
    Cats A; Department of Gastroenterology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands.
    Bleiker EM; Division of Psychosocial Research and Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Snaebjornsson P; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Carvalho B; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Lansdorp-Vogelaar I; Department of Public Health, Erasmus MC, University Medical Center, Rotterdam, The Netherlands.
    Jóźwiak K; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Te Riele H; Division of Biological Stress Response, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    Meijer GA; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    van Leeuwen FE; Department of Epidemiology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
    van Leerdam ME; Department of Gastroenterology, Netherlands Cancer Institute, Plesmanlaan 121, Amsterdam, 1066 CX, The Netherlands. .
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2017 Feb 07; Vol. 17 (1), pp. 112. Date of Electronic Publication: 2017 Feb 07.
    Typ publikacji:
    Clinical Trial; Journal Article; Multicenter Study
    MeSH Terms:
    Research Design*
    Adenoma/*diagnosis
    Colorectal Neoplasms/*diagnosis
    Early Detection of Cancer/*economics
    Hodgkin Disease/*drug therapy
    Neoplasms, Second Primary/*diagnosis
    Procarbazine/*adverse effects
    Adenoma/chemically induced ; Adolescent ; Adult ; Aged ; Antineoplastic Agents/adverse effects ; Antineoplastic Agents/therapeutic use ; Antineoplastic Protocols ; Colonoscopy ; Colorectal Neoplasms/chemically induced ; Cost-Benefit Analysis ; DNA, Neoplasm/analysis ; Early Detection of Cancer/methods ; Feces/chemistry ; Hodgkin Disease/radiotherapy ; Humans ; Immunochemistry ; Middle Aged ; Neoplasms, Second Primary/chemically induced ; Procarbazine/therapeutic use ; Prospective Studies ; Survivors ; Young Adult
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-9 z 9

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies